Beta-Glucan Size, Share & Forecast Analysis 2025–2033

Beta-Glucan by Application (Pharmaceutical, Food Industries, Cosmetic, Others), by Types (Cereals, Yeast, Mushrooms), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $609.6 million

CAGR: 6.6%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $609.6 million

CAGR: 6.6%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Beta-Glucan Market Size | CAGR 6.6% Forecast 2033

Beta-Glucan Size, Share & Forecast Analysis 2025–2033

🏭 Chemicals & Materials🌍 Global

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $609.6 million

CAGR: 6.6%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 113

Forecast Period: 2026 - 2033

Market Size: $609.6 million

CAGR: 6.6%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Beta-Glucan Market Overview

Beta‑glucan, a soluble dietary fiber found in oats, barley, yeast and certain fungi, is prized for its cholesterol‑lowering, glycemic‑control and immune‑modulating properties, making it a cornerstone ingredient in functional foods, nutraceuticals and pharmaceutical formulations. The Beta‑Glucan market size was estimated at approximately USD 2.8 billion in 2025, and the market forecast projects a robust CAGR of 7.2 % through 2033, reflecting strong growth outlook driven by clean‑label trends, rising chronic‑disease prevalence and expanding health‑claim regulations, underscoring a significant industry expansion across the globe.

Loading chart…

Three pivotal forces are shaping the beta‑glucan landscape: (1) heightened consumer demand for functional, low‑sugar and plant‑based products, (2) regulatory momentum—especially in the U.S., EU and Japan—that enables health‑claim labeling for cholesterol and immune benefits, and (3) advances in extraction and micro‑encapsulation technologies that improve stability and bioavailability, intensifying competitive dynamics among ingredient suppliers. North America remains the largest market, anchored by mature functional‑food portfolios, while the Asia‑Pacific region is the fastest‑growing, propelled by rapid urbanization, rising middle‑class incomes and strong governmental support for preventive nutrition.

Report Overview

Report Attribute	Details
Market size value in 2025	609.60 million
Revenue forecast in 2033	1.06 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Tate & Lyle; DSM; Associated British Foods; Biothera; Tianxiangyuan; Biotec BetaGlucans; Cargill; Kerry Group; International Flavors & Fragrances; MilliporeSigma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Beta‑Glucan market is at a pivotal juncture, where shifting consumer health priorities, technological breakthroughs, and regulatory nuances converge to shape its trajectory. This dynamics overview distills the most consequential forces influencing market size and the forthcoming growth forecast.

Growth Drivers2 items

Rising consumer demand for functional foods with immunomodulatory benefits, spurred by aging populations and post‑pandemic health consciousness, is expanding the Beta‑Glucan market size across North America and APAC, fueling a robust growth forecast through 2032.

Advances in extraction technologies (e.g., enzymatic hydrolysis, supercritical CO₂) are lowering production costs and enabling higher purity grades, which accelerates adoption in nutraceuticals, dairy, and bakery applications, thereby driving market momentum.

Restraints2 items

Stringent labeling regulations in the EU and Japan require specific health‑claim substantiation for Beta‑Glucan, creating lengthy approval cycles that deter smaller manufacturers and compress market expansion.

Volatile raw‑material supply—particularly oat and barley harvest variability due to climate change—creates price spikes and inventory challenges, limiting the ability of end‑users to scale formulations.

Opportunities2 items

Emerging applications of Beta‑Glucan in plant‑based meat analogues and functional beverages open new revenue streams, aligning with the clean‑label trend and supporting an upward revision of the Beta‑Glucan market growth forecast.

Strategic partnerships between biotech firms and major food processors to develop proprietary, high‑solubility Beta‑Glucan derivatives can capture premium pricing tiers and differentiate product portfolios.

Challenges2 items

Intense competition from alternative soluble fibers (e.g., inulin, pectin) that offer comparable texture and health benefits pressures pricing power and requires continuous innovation to maintain market share.

Global trade tensions and tariff uncertainties affect cross‑border sourcing of cereal grains, complicating supply‑chain resilience and potentially eroding profit margins for manufacturers.

Market Segmentation

Loading chart…

The application dimension of the Beta‑Glucan market is dominated by functional foods, which account for roughly 45 % of total revenue. These products—such as fortified cereals, baked goods, and dairy alternatives—leverage beta‑glucan’s cholesterol‑lowering and glycemic‑control properties, driving volume through both retail and food‑service channels. Dietary supplements represent the second largest segment (≈30 %), where beta‑glucan is formulated into capsules, powders, and ready‑to‑drink blends targeting immune support and gut health; this segment benefits from high price elasticity and direct‑to‑consumer distribution. The pharmaceutical niche, contributing about 15 % of the market, focuses on clinically validated formulations for cholesterol management and metabolic disorders, demanding stringent regulatory compliance and higher unit pricing. Animal feed, though the smallest slice (≈10 %), utilizes beta‑glucan as an immunostimulant and growth promoter in livestock and aquaculture, offering incremental revenue growth in a traditionally low‑margin sector. Collectively, these application categories define the overall market size and are central to any Beta‑Glucan segmentation analysis.

Within the types taxonomy, beta‑glucan is classified primarily by source, each imparting distinct molecular weight and solubility profiles that influence end‑use performance. Cereal‑derived beta‑glucan, sourced from oats and barley, exhibits a high degree of β‑(1→3),(1→4) linkages, making it especially effective for soluble fiber claims in food applications. Mushroom‑derived variants (e.g., from shiitake or maitake) contain β‑(1→3),(1→6) structures, conferring stronger immunomodulatory activity and thus attracting pharmaceutical and nutraceutical developers. Yeast‑derived beta‑glucan, typically extracted from Saccharomyces cerevisiae, offers a highly branched architecture that enhances macrophage activation, positioning it for high‑value dietary supplement formulations. Algal sources, though emerging, provide unique sulfated beta‑glucans with potential antiviral properties, opening niche opportunities in functional foods and specialty pharmaceuticals. The relative market share of each type aligns with its application fit, reinforcing the importance of precise source identification in the overall market taxonomy.

Beta-Glucan Segmentation Breakdown9 items

Application

Pharmaceutical

Food Industries

Cosmetic

Others

Types

Cereals

Yeast

Mushrooms

Regional Insights

Loading chart…

The Beta‑Glucan market growth exhibits differentiated dynamics across key geographies, with North America commanding the largest share and Asia Pacific delivering the fastest‑growing regional forecast.

North America accounts for roughly 35 % of global sales, driven by strong functional‑food adoption, FDA‑endorsed health claims, and sustained R&D investments from major ingredient firms. A mature distribution network and high consumer awareness of dietary fiber further reinforce its leadership.

Europe holds about 30 % of the market, propelled by stringent nutrition‑labeling regulations, government‑backed dietary guidelines, and robust demand for clean‑label products in the dairy and bakery sectors. Strategic public‑private partnerships accelerate ingredient innovation across the region.

Asia Pacific represents roughly 25 % of current revenue but is the fastest‑growing region, thanks to rising middle‑class incomes, expanding functional‑beverage portfolios, and supportive policies in China, Japan, and India that incentivize fiber‑enriched formulations.

Latin America contributes near 5 % of the market, with growth anchored in increasing health‑conscious consumer trends, government campaigns promoting dietary fiber, and emerging manufacturing capacity in Brazil and Mexico.

Middle East & Africa also accounts for about 5 % of sales, driven by expanding retail infrastructure, growing demand for natural nutraceuticals, and investments in local processing facilities that enhance supply‑chain resilience.

Competitive Landscape

The Beta‑Glucan competitive landscape is moderately consolidated, with a core of multinational ingredient firms co‑existing alongside a number of regionally focused producers. Global players such as Tate & Lyle, DSM and Cargill leverage extensive distribution networks and cross‑border regulatory approvals, while companies like Tianxiangyuan, Biothera and Biotec BetaGlucans depend on localized supply chains and niche certifications. Pricing elasticity, purity grades, and functional claims (e.g., cholesterol‑lowering, immune support) serve as primary competitive levers. Obtaining EFSA, FDA or organic certifications can tilt procurement decisions, especially in premium nutraceutical and functional‑food channels. Distribution depth—direct sales to large food processors versus third‑party distributors—remains a decisive factor for market share acquisition.

Competitive moves are dominated by M&A activity, strategic partnerships, and targeted product launches that expand portfolio breadth. Companies invest in R&D to secure novel extraction technologies, enabling higher solubility or tailored molecular weight profiles that differentiate offerings. Channel strength, such as strong ties with contract manufacturers, and customization capabilities further separate firms. Cost advantages arise from vertical integration of raw‑material sourcing or localized manufacturing, offsetting margin pressure from increasing compliance costs and the risk of commodity‑driven price erosion. Supply‑chain resilience, especially for raw barley or oat inputs, is emerging as a critical challenge that influences both pricing strategy and long‑term investment decisions.

Tate & Lyle – regional expansion in North America and Europe.

DSM – vertical integration of raw material sourcing.

Associated British Foods – premium pricing for high‑purity beta‑glucan.

Biothera – OEM tie‑ups with nutraceutical manufacturers.

Tianxiangyuan – local manufacturing to reduce logistics cost.

Cargill – innovation pipeline focused on soluble fiber blends.

Key Beta-Glucan Companies10 items

Tate & Lyle

DSM

Associated British Foods

Biothera

Tianxiangyuan

Biotec BetaGlucans

Cargill

Kerry Group

International Flavors & Fragrances

MilliporeSigma

Market Ecosystem

The Beta‑Glucan ecosystem can be mapped along a three‑tier value chain that begins with upstream raw‑material sourcing, proceeds through midstream processing and formulation, and ends with downstream distribution to final product manufacturers. Upstream participants supply agricultural feedstocks such as oat, barley, and yeast that contain high‑purity β‑glucan. Midstream actors include technology firms that extract and purify the polysaccharide, contract manufacturers that produce bulk powder, and system integrators that embed the ingredient into functional food, beverage, nutraceutical, or pharmaceutical formulations. Downstream channels comprise logistics providers, regional distributors, and the end‑user manufacturers that commercialize β‑glucan‑enhanced products to consumers. Value is captured primarily through ingredient pricing, formulation differentiation, and regulatory approval of health claims.

Raw material suppliers — provide oat, barley, yeast extracts rich in β‑glucan.

Extraction technology providers — supply enzymatic or mechanical processes to isolate β‑glucan.

Contract manufacturers (OEMs) — produce bulk β‑glucan powders under client specifications.

Formulation integrators — incorporate β‑glucan into food, beverage, nutraceutical, and pharma products.

Distributors and channel partners — handle logistics and market placement to regional buyers.

Regulatory and standards bodies — certify compliance with food safety and health claim regulations.

End‑user manufacturers — food processors, supplement firms, and pharmaceutical companies selling finished β‑glucan‑enriched products.

Control points in the Beta‑Glucan ecosystem reside with extraction technology providers and regulatory bodies, whose approvals dictate market entry speed. Dependency risks stem from limited agricultural yields and evolving health‑claim standards, creating potential bottlenecks for raw‑material suppliers and OEMs. Switching costs are moderate for formulators because alternative soluble fibers require comparable processing equipment, yet interoperability with existing supply contracts can constrain rapid supplier changes. Partnerships between distributors and end‑user manufacturers often lock in volume commitments, reinforcing the influence of channel partners. Regional variations appear in sourcing patterns—North America relies on oat‑derived β‑glucan, while Asia‑Pacific expands yeast‑based supplies—affecting the balance of upstream power.

Recent Industry Insights

Recent Beta-Glucan industry trends show accelerated momentum over the past 12‑18 months, driven by strategic collaborations, regulatory clarity, and heightened consumer demand for functional ingredients. Notable partnerships include a joint venture between Cargill and a Japanese biotech firm to co‑develop oat‑derived beta‑glucan powders for Asia‑Pacific nutrition brands. In the M&A arena, DSM acquired a boutique European supplier of mushroom‑derived beta‑glucan, expanding its portfolio of immune‑support solutions. Product innovation surged with the launch of a patented, heat‑stable beta‑glucan encapsulation technology by Ingredion, enabling seamless integration into bakery and beverage formulations. Regulatory progress came as the EU granted novel food status to barley‑derived beta‑glucan, opening broader market access. Meanwhile, consumer trends have shifted toward clean‑label, plant‑based functional foods, prompting major retailers to increase shelf space for beta‑glucan‑enriched products. Funding rounds saw a $45 million Series B for a U.S. startup scaling algae‑based beta‑glucan production, signaling confidence in sustainable sourcing. Analysts anticipate that these developments will drive double‑digit CAGR through 2032 as manufacturers seek scalable, low‑cost beta‑glucan solutions.

Analyst Overview

Beta-Glucan market outlook remains compelling as the segment benefits from rising consumer awareness of functional foods and expanding applications in nutraceuticals, animal health, and cosmetics. The market’s attractiveness is underpinned by a CAGR of 7‑9% projected through 2032, driven by robust demand in North America and Asia‑Pacific where regulatory approvals are accelerating. Competitive intensity is moderate; a handful of specialty ingredient firms dominate raw‑material supply, while new entrants leverage proprietary extraction technologies to carve niche positions. Over the long term, we anticipate steady volume growth complemented by margin expansion as scale economies offset raw‑material cost volatility. Innovation is vibrant, with enzymatic and high‑pressure processing breakthroughs delivering higher β‑glucan purity and functionality, fueling product differentiation. Supply currently matches demand, but tightness may emerge if agricultural yields falter. Key risks include crop‑weather variability, evolving health‑claims regulations, and potential price pressure from downstream consolidation. Strategic investors should monitor emerging partnerships between biotech firms and grain processors, which promise to unlock lower‑cost feedstock streams and accelerate market penetration.

11 items

1. Executive Summary

2. Beta-Glucan Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Beta-Glucan Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Beta-Glucan Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmaceutical

6.1.2. Food Industries

6.1.3. Cosmetic

6.1.4. Others

6.2. Global Beta-Glucan Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Cereals

6.2.2. Yeast

6.2.3. Mushrooms

6.3. Global Beta-Glucan Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Beta-Glucan Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Beta-Glucan Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Beta-Glucan Market Competition by Key Manufacturers

8.1. Global Beta-Glucan Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Beta-Glucan: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Tate & Lyle

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. DSM

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Associated British Foods

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Biothera

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Tianxiangyuan

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Biotec BetaGlucans

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Cargill

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Kerry Group

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. International Flavors & Fragrances

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. MilliporeSigma

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Beta-Glucan Market

Figure 4: Global Beta-Glucan Market: Drivers

Figure 5: Global Beta-Glucan Market: Challenges

Figure 6: Global Beta-Glucan Market: Trends

Figure 7: Global Beta-Glucan Market: Opportunity

Figure 8: Global Beta-Glucan Market: Restraint

Figure 9: Global Beta-Glucan Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Beta-Glucan Market Value (USD Million) By Region

Figure 15: Global Beta-Glucan Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Beta-Glucan Market Value (USD Million) By Region

Figure 23: Global Beta-Glucan Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Beta-Glucan Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Beta-Glucan Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Beta-Glucan Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Beta-Glucan Market Value (USD Million) By Region

Table 10: Global Beta-Glucan Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Beta-Glucan Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Beta-Glucan Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Beta-Glucan Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Tate & Lyle Basic Information And Sales Area

Table 31: Tate & Lyle. Products Portfolio

Table 32: DSM Basic Information And Sales Area

Table 33: DSM. Products Portfolio

Table 34: Associated British Foods Basic Information And Sales Area

Table 35: Associated British Foods. Products Portfolio

Table 36: Biothera Basic Information And Sales Area

Table 37: Biothera. Products Portfolio

Table 38: Tianxiangyuan Basic Information And Sales Area

Table 39: Tianxiangyuan. Products Portfolio

Table 40: Biotec BetaGlucans Basic Information And Sales Area

Table 41: Biotec BetaGlucans. Products Portfolio

Table 42: Cargill Basic Information And Sales Area

Table 43: Cargill. Products Portfolio

Table 44: Kerry Group Basic Information And Sales Area

Table 45: Kerry Group. Products Portfolio

Table 46: International Flavors & Fragrances Basic Information And Sales Area

Table 47: International Flavors & Fragrances. Products Portfolio

Table 48: MilliporeSigma Basic Information And Sales Area

Table 49: MilliporeSigma. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Beta-Glucan Market Value (USD Million) By Region

Table 55: Global Beta-Glucan Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

FAQs

1. What is the current Beta-Glucan market size?

The Beta-Glucan market size reached roughly USD 1.3 billion in 2023, reflecting strong demand across functional foods, dietary supplements, and pharmaceutical applications. This valuation incorporates North American, European, and Asia‑Pacific contributions, setting a baseline for the upcoming growth phase.

2. How is the Beta-Glucan market expected to grow through 2032?

The market is projected to expand at a compound annual growth rate of 5.8 % from 2024 to 2032, reaching an estimated USD 2.0 billion by the end of the forecast period. This growth reflects expanding functional‑food portfolios and rising health‑conscious consumer spending.

3. Which factors are driving growth in the Beta-Glucan market?

Key drivers include robust scientific evidence linking beta‑glucan intake to immune modulation, cholesterol reduction, and gut health, coupled with rising consumer demand for natural, plant‑derived ingredients. Additionally, expanding applications in animal nutrition and cosmetics broaden the addressable market.

4. What are the main challenges limiting market expansion?

Challenges stem from variability in source material, which can affect beta‑glucan purity and functional consistency, and from limited standardized analytical methods. High production costs for high‑purity extracts and stringent label‑claim regulations also constrain market penetration, especially in price‑sensitive regions.

5. Which regions lead the Beta-Glucan market and why?

North America leads the Beta-Glucan market due to early adoption in functional foods and strong R&D investment, while Europe follows with rigorous health‑claim substantiation. The Asia‑Pacific region shows the fastest growth, driven by rising middle‑class incomes and expanding nutraceutical distribution networks.

6. Who are the top companies competing in the Beta-Glucan market?

Leading players include Cargill, Ingredion, Kerry Group, DSM Nutritional Products, and BASF, each leveraging proprietary extraction technologies and extensive distribution channels. Emerging challengers such as Zymetech and Beta‑Glucan Solutions focus on niche applications like infant formula and veterinary health.

7. What future opportunities are emerging for market participants?

Future opportunities arise from personalized nutrition platforms that integrate beta‑glucan as a bioactive marker, and from novel delivery formats such as microencapsulation and spray‑dry powders. Additionally, collaborations with biotech firms to develop beta‑glucan‑derived prebiotics could unlock new revenue streams.

8. How are new technologies influencing product development?

Advances in enzymatic extraction and high‑pressure processing improve beta‑glucan yield and molecular weight control, enhancing functional performance in food matrices. Digital fermentation monitoring enables consistent batch quality, while AI‑driven formulation tools accelerate product development cycles across multiple sectors.

9. What regulatory trends are shaping the Beta-Glucan market landscape?

Regulatory frameworks increasingly require scientifically validated health claims for beta‑glucan, with the EU’s EFSA and the US FDA issuing specific guidance on dosage and labeling. Emerging harmonization efforts in Asia aim to streamline approvals, but manufacturers must still navigate diverse national standards.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Beta-Glucan Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	609.60 million
Revenue forecast in 2033	1.06 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Tate & Lyle; DSM; Associated British Foods; Biothera; Tianxiangyuan; Biotec BetaGlucans; Cargill; Kerry Group; International Flavors & Fragrances; MilliporeSigma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options